Breast cancer in Brazil: epidemiology and treatment challenges

被引:47
作者
Cecilio, Adma Poliana [1 ]
Takakura, Erika Tomie [1 ]
Jumes, Jaqueline Janaina [1 ]
dos Santos, Jeane Wilhelm [1 ]
Herrera, Ana Cristina [2 ]
Victorino, Vanessa Jacob [3 ]
Panis, Carolina [1 ]
机构
[1] State Univ West Parana, UNIOESTE, Toledo, Parana, Brazil
[2] PUC, Campus Londrina, Parana, Brazil
[3] Sao Paulo Univ FM USP, Sch Med, Sao Paulo, Brazil
来源
BREAST CANCER-TARGETS AND THERAPY | 2015年 / 7卷
关键词
breast cancer; treatment; prevention; epidemiology; Brazil; cancer screening; mammograms; health policies;
D O I
10.2147/BCTT.S50361
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Notwithstanding the advances in tumor research, diagnosis, and treatment, breast cancer is still a challenge worldwide. This global burden of disease has been associated with population aging and the persistence of cancer-related behaviors. The number of women diagnosed with breast cancer has been estimated as increasing, especially in middle-income countries such as Brazil. Estimates from the Instituto Nacional de Cancer (INCA) point to breast cancer as the major malignant neoplasia in Brazilian women and the main cause of death from cancer in the country. This fact has been associated with increased life expectancy, urbanization, and cancer-related behaviors. Given this scenario, it is clear that there is a need for identifying and discussing which factors have substantially contributed to this growing number of cases in Brazil, including access to treatment, prevention and early diagnosis, weaknesses of the local health policy, and intrinsic genetic peculiarities of the Brazilian population. This review aims to address the role of such factors.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 40 条
  • [1] Adami HO, 2008, TXB CANC EPIDEMIOLOG
  • [2] Albala C, 1997, REV MED CHILE, V125, P719
  • [3] Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010
    Anderson, Benjamin O.
    Cazap, Eduardo
    El Saghir, Nagi S.
    Yip, Cheng-Har
    Khaled, Hussein M.
    Otero, Isabel V.
    Adebamowo, Clement A.
    Badwe, Rajendra A.
    Harford, Joe B.
    [J]. LANCET ONCOLOGY, 2011, 12 (04) : 387 - 398
  • [4] Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer
    Anelli, A
    Brentani, RR
    Gadelha, AP
    de Albuquerque, AA
    Soares, F
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (03) : 428 - 432
  • [5] [Anonymous], 2011, COB MAM PROADESSII F
  • [6] Baracat F F, 1988, Rev Paul Med, V106, P14
  • [7] Boyle P., 2008, World Cancer Report 2008
  • [8] Costa Luciano José Megale, 2002, Sao Paulo Med. J., V120, P113
  • [9] DOLL R, 1990, EUR J CANCER, V26, P500
  • [10] Dufloth Rozany Mucha, 2005, Sao Paulo Med. J., V123, P192, DOI 10.1590/S1516-31802005000400007